FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051280604> ?p ?o ?g. }

• W2051280604 endingPage "391" @default.
• W2051280604 startingPage "387" @default.
• W2051280604 abstract "Gluten-free diet (GFD) plays a key role in the treatment of celiac disease (CD), but it is difficult to evaluate the effect of GFD on the improvement of villous architecture using sensitive, non-invasive tests. Aim of this study is to evaluate anti-transglutaminase (tTG) antibodies in the follow-up of CD to detect histologic recovery. We studied 42 consecutive patients with CD. In all the patients anti-tTG antibodies (evaluated by the enzyme linked immunosorbent assay method) and EGDscopy with multiple bioptic samples before GFD and then 6, 12, and 18 months after GFD were evaluated. For comparison, a sorbitol H2-breath test (H2-BT) and anti-endomysium (EMA) antibodies test were carried out concomitantly. Anti-tTG results were positive in 36 of 42 patients before GFD (80.95%), while they were positive in 11 of 34 (32.35%), 1 of 17 (5.88%), and 0 of 6 (0%) of patients with a persistence in histologic lesions 6, 12, and 18 months of GFD respectively, without any correlation with persistence of histologic lesions (P = NS). Also EMA failed to show correlation with improvement of histologic lesions. They were positive in 31 of 42 patients before GFD (73.80%), while they were positive in 18 of 34 (52.94%), 3 of 17 (17.64%), and 0 of 6 (0%) cases 6, 12, and 18 months of GFD respectively (P = NS). Regarding sorbitol H2-BT, it was positive in 40 of 42 (95.24%) patients before GFD, while it was positive in 31 of 34 (91.17%), 13 of 17 (76.47%), and 4 of 6 (50%) of patients with a persistence in histologic lesions 6, 12, and then 18 months after GFD starting (see Fig. 2, infra). So, anti-tTG and EMA were ineffective in assessing the histologic recovery at each follow-up visit (P = NS), while sorbitol H2-BT seems more effective than anti-tTG and EMA in this field (P < 0.0001 sorbitol H2-BT versus anti-tTG and versus EMA at 18 months after gluten withdrawal). Thirty-eight of 42 (90.47%) patients adhered to a strict GFD. Four patients were found to have occasional dietary transgression, and in all we noted a progressive decreasing of anti-tTG after 6 months of GFD and negative anti-tTG after 12 months of GFD, but sorbitol H2-BT persisted being positive during the entire follow-up. Intestinal damage persisted during the follow-up, despite anti-tTG and EMA negativity, and worsened in the presence of dietary lapses. Anti-tTG does not seem effective to assess histologic recovery in the follow-up of celiac patients after they have started GFD due to its poor correlation with histologic damage." @default.
• W2051280604 created "2016-06-24" @default.
• W2051280604 creator A5003927001 @default.
• W2051280604 creator A5012022582 @default.
• W2051280604 creator A5020671787 @default.
• W2051280604 date "2003-11-01" @default.
• W2051280604 modified "2023-10-06" @default.
• W2051280604 title "Lack of Usefulness of Anti-Transglutaminase Antibodies in Assessing Histologic Recovery After Gluten-Free Diet in Celiac Disease" @default.
• W2051280604 cites W1968994572 @default.
• W2051280604 cites W1992457612 @default.
• W2051280604 cites W1999102015 @default.
• W2051280604 cites W2018179601 @default.
• W2051280604 cites W2036798664 @default.
• W2051280604 cites W2040906496 @default.
• W2051280604 cites W2043583169 @default.
• W2051280604 cites W2043856196 @default.
• W2051280604 cites W2044830949 @default.
• W2051280604 cites W2065433711 @default.
• W2051280604 cites W2067509342 @default.
• W2051280604 cites W2074500614 @default.
• W2051280604 cites W2075805805 @default.
• W2051280604 cites W2078527576 @default.
• W2051280604 cites W2081757045 @default.
• W2051280604 cites W2321872434 @default.
• W2051280604 cites W2323975700 @default.
• W2051280604 cites W2331892306 @default.
• W2051280604 cites W4237977256 @default.
• W2051280604 cites W4245464873 @default.
• W2051280604 cites W4252341898 @default.
• W2051280604 cites W4294305087 @default.
• W2051280604 doi "https://doi.org/10.1097/00004836-200311000-00007" @default.
• W2051280604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14564185" @default.
• W2051280604 hasPublicationYear "2003" @default.
• W2051280604 type Work @default.
• W2051280604 sameAs 2051280604 @default.
• W2051280604 citedByCount "84" @default.
• W2051280604 countsByYear W20512806042012 @default.
• W2051280604 countsByYear W20512806042013 @default.
• W2051280604 countsByYear W20512806042014 @default.
• W2051280604 countsByYear W20512806042015 @default.
• W2051280604 countsByYear W20512806042016 @default.
• W2051280604 countsByYear W20512806042017 @default.
• W2051280604 countsByYear W20512806042018 @default.
• W2051280604 countsByYear W20512806042019 @default.
• W2051280604 countsByYear W20512806042020 @default.
• W2051280604 countsByYear W20512806042021 @default.
• W2051280604 countsByYear W20512806042022 @default.
• W2051280604 crossrefType "journal-article" @default.
• W2051280604 hasAuthorship W2051280604A5003927001 @default.
• W2051280604 hasAuthorship W2051280604A5012022582 @default.
• W2051280604 hasAuthorship W2051280604A5020671787 @default.
• W2051280604 hasConcept C126322002 @default.
• W2051280604 hasConcept C127413603 @default.
• W2051280604 hasConcept C142724271 @default.
• W2051280604 hasConcept C159654299 @default.
• W2051280604 hasConcept C178498320 @default.
• W2051280604 hasConcept C181199279 @default.
• W2051280604 hasConcept C185592680 @default.
• W2051280604 hasConcept C187320778 @default.
• W2051280604 hasConcept C203014093 @default.
• W2051280604 hasConcept C2776336767 @default.
• W2051280604 hasConcept C2776779347 @default.
• W2051280604 hasConcept C2779134260 @default.
• W2051280604 hasConcept C2780349322 @default.
• W2051280604 hasConcept C2781009140 @default.
• W2051280604 hasConcept C3019118998 @default.
• W2051280604 hasConcept C31903555 @default.
• W2051280604 hasConcept C55493867 @default.
• W2051280604 hasConcept C71924100 @default.
• W2051280604 hasConcept C90924648 @default.
• W2051280604 hasConceptScore W2051280604C126322002 @default.
• W2051280604 hasConceptScore W2051280604C127413603 @default.
• W2051280604 hasConceptScore W2051280604C142724271 @default.
• W2051280604 hasConceptScore W2051280604C159654299 @default.
• W2051280604 hasConceptScore W2051280604C178498320 @default.
• W2051280604 hasConceptScore W2051280604C181199279 @default.
• W2051280604 hasConceptScore W2051280604C185592680 @default.
• W2051280604 hasConceptScore W2051280604C187320778 @default.
• W2051280604 hasConceptScore W2051280604C203014093 @default.
• W2051280604 hasConceptScore W2051280604C2776336767 @default.
• W2051280604 hasConceptScore W2051280604C2776779347 @default.
• W2051280604 hasConceptScore W2051280604C2779134260 @default.
• W2051280604 hasConceptScore W2051280604C2780349322 @default.
• W2051280604 hasConceptScore W2051280604C2781009140 @default.
• W2051280604 hasConceptScore W2051280604C3019118998 @default.
• W2051280604 hasConceptScore W2051280604C31903555 @default.
• W2051280604 hasConceptScore W2051280604C55493867 @default.
• W2051280604 hasConceptScore W2051280604C71924100 @default.
• W2051280604 hasConceptScore W2051280604C90924648 @default.
• W2051280604 hasIssue "5" @default.
• W2051280604 hasLocation W20512806041 @default.
• W2051280604 hasLocation W20512806042 @default.
• W2051280604 hasOpenAccess W2051280604 @default.
• W2051280604 hasPrimaryLocation W20512806041 @default.
• W2051280604 hasRelatedWork W1899913413 @default.
• W2051280604 hasRelatedWork W1958565298 @default.
• W2051280604 hasRelatedWork W1972567037 @default.
• W2051280604 hasRelatedWork W1992457612 @default.

• next